表柔比星治疗转移性肾癌的II期试验：北加利福尼亚肿瘤学组的一项研究 - Suppr | 超能文献

Phase II trial of esorubicin in the treatment of metastatic carcinoma of the kidney: a study of the Northern California Oncology Group.

作者信息

Carlson R W, Williams R D, Billingham M E, Kohler M, Torti F M

出版信息

Cancer Treat Rep. 1987 Jul-Aug;71(7-8):767-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Phase II trial of esorubicin in the treatment of metastatic carcinoma of the kidney: a study of the Northern California Oncology Group.表柔比星治疗转移性肾癌的II期试验：北加利福尼亚肿瘤学组的一项研究

Cancer Treat Rep. 1987 Jul-Aug;71(7-8):767-8.

2

Esorubicin in refractory metastatic carcinoma of the breast: a Northern California Oncology Group Study.

Cancer Treat Rep. 1987 Apr;71(4):427-8.

3

Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.

Cancer Treat Rep. 1985 Jan;69(1):143-4.

4

Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.表柔比星用于晚期结直肠癌且未接受过化疗患者的II期研究：伊利诺伊州癌症协会试验

Cancer Treat Rep. 1987 Jul-Aug;71(7-8):765-6.

5

Phase II trial of esorubicin in patients with advanced colorectal carcinoma.表柔比星用于晚期结直肠癌患者的II期试验。

Cancer Treat Rep. 1986 Oct;70(10):1241-2.

6

Phase II study of 4'-epi-doxorubicin in metastatic renal cancer.4'-表阿霉素治疗转移性肾癌的II期研究。

Cancer Treat Rep. 1982 May;66(5):1219-21.

7

Phase II trial of esorubicin in patients with advanced melanoma.表柔比星用于晚期黑色素瘤患者的II期试验。

Cancer Treat Rep. 1987 Mar;71(3):325-6.

8

Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.贝克抗叶酸制剂用于转移性肾细胞癌的II期试验：一项西南肿瘤协作组研究

Cancer Treat Rep. 1980;64(12):1387-8.

9

European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer.欧洲癌症研究与治疗组织（EORTC）关于低剂量每周一次表柔比星治疗转移性前列腺癌的II期研究。

Cancer Treat Rep. 1987 Dec;71(12):1317-8.

10

Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTC.

Eur J Cancer Clin Oncol. 1989 Jun;25(6):995-6. doi: 10.1016/0277-5379(89)90161-2.

引用本文的文献

1

Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.

Invest New Drugs. 1989 Jul;7(2-3):235-8. doi: 10.1007/BF00170865.

2

Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.

Invest New Drugs. 1989 Nov;7(4):333-6. doi: 10.1007/BF00173763.

3

Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685).

Invest New Drugs. 1990 Aug;8(3):329-32. doi: 10.1007/BF00171849.